Nanobiotechnology promotes noninvasive high-intensity focused ultrasound cancer surgery (Q38217698)

31 August 2017

Nanobiotechnology promotes noninvasive high-intensity focused ultrasound cancer surgery (English)

1 reference

31 August 2017

0 references

Yu Chen

1

1 reference

PubMed ID

24898413

31 August 2017

Hangrong Chen

series ordinal

2

1 reference

PubMed ID

24898413

31 August 2017

Jianlin Shi

series ordinal

3

1 reference

31 August 2017

4 June 2014

1 reference

Advanced Healthcare Materials

31 August 2017

1 reference

31 August 2017

4

1 reference

31 August 2017

1

1 reference

31 August 2017

158-165

1 reference

High-intensity focused ultrasound in the treatment of solid tumours.

31 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Comparison of cryoablation, radiofrequency ablation and high-intensity focused ultrasound for treating small renal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Focused ultrasound as a local therapy for liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Exploiting ultrasound-mediated effects in delivering targeted, site-specific cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Targeted renal therapies through microbubbles and ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

High-intensity focused ultrasound: current potential and oncologic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

High intensity focused ultrasound: surgery of the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Ultrasound-biophysics mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Clinical and future applications of high intensity focused ultrasound in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

High intensity focused ultrasound ablation: a new therapeutic option for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

The effects of Magnetic Resonance Imaging-guided High-Intensity Focused Ultrasound ablation on human cadaver breast tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

MR-guided high-intensity focused ultrasound: current status of an emerging technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Sonographically guided high-intensity focused ultrasound for the management of uterine fibroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

A new theranostic system based on gold nanocages and phase-change materials with unique features for photoacoustic imaging and controlled release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Progress and problems in the application of focused ultrasound for blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Microbubbles from gas-generating perfluorohexane nanoemulsions for targeted temperature-sensitive ultrasonography and synergistic HIFU ablation of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Superparamagnetic PLGA-iron oxide microcapsules for dual-modality US/MR imaging and high intensity focused US breast cancer ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

MRI-guided gas bubble enhanced ultrasound heating in in vivo rabbit thigh.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Development and characterization of a nano-scale contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Microbubbles in medical imaging: current applications and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Aptamer-conjugated nanobubbles for targeted ultrasound molecular imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Functionalized mesoporous silica materials for controlled drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Construction of homogenous/heterogeneous hollow mesoporous silica nanostructures by silica-etching chemistry: principles, synthesis, and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Colloidal HPMO nanoparticles: silica-etching chemistry tailoring, topological transformation, and nano-biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Au-nanoparticle coated mesoporous silica nanocapsule-based multifunctional platform for ultrasound mediated imaging, cytoclasis and tumor ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

An intelligent nanotheranostic agent for targeting, redox-responsive ultrasound imaging, and imaging-guided high-intensity focused ultrasound synergistic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Multifunctional mesoporous composite nanocapsules for highly efficient MRI-guided high-intensity focused ultrasound cancer surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Image-guided focused ultrasound ablation of breast cancer: current status, challenges, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

MRI-guided focused ultrasound treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Alternatives to gadolinium-based metal chelates for magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Challenges for molecular magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Real-time volumetric MRI thermometry of focused ultrasound ablation in vivo: a feasibility study in pig liver and kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Structure-property relationships in manganese oxide--mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

What nephrologists need to know about gadolinium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Mesoporous silica nanoparticles in medicine--recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Aqueous colloidal mesoporous nanoparticles with ethenylene-bridged silsesquioxane frameworks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Facile synthesis of magnetite/perfluorocarbon co-loaded organic/inorganic hybrid vesicles for dual-modality ultrasound/magnetic resonance imaging and imaging-guided high-intensity focused ultrasound ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Physical basis and biological mechanisms of gold nanoparticle radiosensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Inorganic Nanoparticles for MRI Contrast Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

Urchin-shaped manganese oxide nanoparticles as pH-responsive activatable T1 contrast agents for magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201400127

21 January 2018

Identifiers

DOI

10.1002/ADHM.201400127

1 reference

31 August 2017

1 reference

PubMed ID

24898413